Document Detail


Cardioprotective effects of electroacupuncture pretreatment on patients undergoing heart valve replacement surgery: a randomized controlled trial.
MedLine Citation:
PMID:  20172127     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Cardiac ischemia-reperfusion injury after cardiopulmonary bypass contributes to postoperative morbidity and mortality in patients with open-heart surgery. This randomized controlled trial was designed to address the protective effects of electroacupuncture (EA) pretreatment on myocardial injury in patients undergoing heart valve replacement surgery. METHODS: Sixty patients with acquired heart valve disease were randomly allocated to the EA pretreatment group or the control group. Patients in the EA group received EA stimulus at bilateral Neiguan (PC 6), Lieque (LU 7), and Yunmen (LU 2) for 30 minutes each day for five consecutive days before surgery. Hemodynamic data, mechanical ventilation time, inotropic drug use in the intensive care unit, serum cardiac troponin I concentrations, morbidities, and mortalities were compared between the two groups. This trial is registered with ClinicalTrials.gov, number NCT00732459. RESULTS: At 6 hours, 12 hours, and 24 hours after reperfusion, levels of serum cardiac troponin I were significantly decreased in the EA group (5.74 +/- 0.67, 6.22 +/- 0.66, and 5.21 +/- 0.58) compared with that in the control group (7.89 +/- 0.74, 8.34 +/- 1.08, and 7.57 +/- 0.89, p < 0.05). The EA pretreatment significantly reduced overall serum troponin I release at 6 hours, 12 hours, and 24 hours after aortic cross-clamp removal. Meanwhile, EA pretreatment also reduced the inotrope score at 12 hours, 24 hours, and 48 hours after the intensive care unit arrival and shortened intensive care unit stay time (p < 0.05). CONCLUSIONS: The present study demonstrated that EA pretreatment may alleviate cardiac ischemia-reperfusion injury in adult patients undergoing heart valve replacements. This simple and convenient treatment has the potential to be used in the clinic for reducing myocardial injury in patients with heart valve replacement surgery.
Authors:
Lifang Yang; Jian Yang; Qiang Wang; Min Chen; Zhihong Lu; Shaoyang Chen; Lize Xiong
Related Documents :
6696197 - Microbiologic efficacy of a surgically constructed nipple valve.
9930427 - Reoperation on stentless aortic xenografts.
16837777 - State of the art percutaneous intervention for the treatment of valvular heart disease:...
3463607 - Portable lung ventilators: the potential risk from bacterial colonisation.
15366437 - Heartmate vented-electric left ventricular assist system: technique for intrathoracic o...
21533977 - Cardiac resynchronization therapy: the issue of non-response.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  89     ISSN:  1552-6259     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-02-22     Completed Date:  2010-03-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  781-6     Citation Subset:  AIM; IM    
Copyright Information:
2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Affiliation:
Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00732459
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiopulmonary Bypass / adverse effects*
Cardiotonic Agents / therapeutic use
Electroacupuncture*
Female
Heart Valve Prosthesis Implantation* / adverse effects
Humans
Intensive Care Units
Ischemic Preconditioning, Myocardial*
Length of Stay
Male
Middle Aged
Myocardial Reperfusion Injury / etiology,  prevention & control*
Preoperative Care*
Single-Blind Method
Troponin I / blood
Chemical
Reg. No./Substance:
0/Cardiotonic Agents; 0/Troponin I
Comments/Corrections
Comment In:
Ann Thorac Surg. 2010 Mar;89(3):786   [PMID:  20172128 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of preoperative statin therapy on patients undergoing isolated and combined valvular heart su...
Next Document:  EuroSCORE Performance in Valve Surgery: A Meta-Analysis.